Illumina shareholders vote to install Carl Icahn board nominee, oust chair
Carl Icahn has accused Illumina's management and board of poor oversight, particularly with regard to the company's acquisition of cancer test maker Grail.
Carl Icahn has accused Illumina's management and board of poor oversight, particularly with regard to the company's acquisition of cancer test maker Grail.
The Food and Drug Administration is set to announce soon whether it will grant full approval to lecanemab for the treatment of Alzheimer's.
More Americans plan to have gatherings over the Memorial Day weekend, even though costs for some staples are rising.
The Supreme Court on Thursday limited the Environmental Protection Agency’s authority to police water pollution in certain wetlands.
Some 60% of Generation Z are investing their money, according to a new report by FINRA and the CFA Institute.
Pfizer Inc. PFE said Thursday it has received full Food and Drug Administration approval for its Paxlovid oral treatment for COVID-19 for use in adult...
Ford CEO Jim Farley used Warren Buffett-backed BYD as the prime example of a Chinese automaker that has successfully developed and sold electric vehicles.
Boston Fed President Collins said signs of waning inflation suggest the central bank may be "at, or near, the point" where it can stop raising...